Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The objective is to evaluate the safety and pharmacokinetic characteristics after co-administration of JW0106 and C2101 and administration of JW0107 in healthy volunteers under fasting conditions.
Pharmacokinetic characteristics: Describes the blood concentration statistically by pharmacokinetic blood collection time and treatment group.
Safety: All adverse events are summarized in terms of the number of subjects, expression rate, and number of expressions of adverse reactions by treatment group.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Sequence 1 | Other | (Period 1/3: Treatment A) (Period 2/4: Treatment B) Treatment A: JW0106 1 tablet + C2101 1 tablet Treatment B: JW0107 1 tablet |
|
| Sequence 2 | Other | (Period 1/3: Treatment B) (Period 2/4: Treatment A) Treatment A: JW0106 1 tablet + C2101 1 tablet Treatment B: JW0107 1 tablet |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Treatment A: JW0106 1 tablet + C2101 1 tablet | Drug |
|
| Measure | Description | Time Frame |
|---|---|---|
| AUCt | Describes the blood concentration statistically by pharmacokinetic blood collection time and treatment group. | Day 1(0 hour~12 hour), Day 2(24 hour), Day 3(48 hour), Day 4(72 hour) |
| Cmax | Describes the blood concentration statistically by pharmacokinetic blood | Day 1(0 hour~12 hour), Day 2(24 hour), Day 3(48 hour), Day 4(72 hour) |
Not provided
Not provided
Inclusion Criteria:
Healthy volunteers
Exclusion Criteria:
Subjects does not meet the inclusion Criteria
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinical Trial Center, Jeonbuk National University Hospital | Jeonju | Korea | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Treatment B: JW0107 1 tablet | Drug |
|
|
|